Neurable licenses non-invasive BCI tech for consumer wearables
Neurable, a Boston-based BCI startup, announced it will license its non-invasive brain-computer interface technology to consumer wearable companies. Unlike Neuralink's surgical implants, Neurable uses EEG sensors and AI to read neural signals without surgery. The company raised $35 million in a Series A in December to scale commercialization. It has partnered with HP's HyperX on a gaming headset and with iMotions for research. Neurable now seeks to integrate its tech into headphones, hats, glasses, and headbands across health, productivity, and gaming sectors. CEO Ramses Alcaide emphasized data privacy, claiming HIPAA compliance, encryption, and anonymization. User data can be used for AI training only with explicit consent. Alcaide called the current moment an "inflection point" for scalable neuro-technology business models.
Key facts
- Neurable licenses non-invasive BCI tech to consumer wearables.
- Raised $35 million Series A in December.
- Partners include HP's HyperX and iMotions.
- Tech uses EEG sensors and AI to analyze brain activity.
- CEO Ramses Alcaide cites HIPAA compliance and data anonymization.
- User data used for AI training only with consent.
- Targets health, athletic, productivity, and gaming products.
- Alcaide describes neuro-technology at an 'inflection point'.
Entities
Institutions
- Neurable
- Neuralink
- HP Inc.
- HyperX
- iMotions
- TechCrunch